Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004828
Filing Date
2025-07-03
Accepted
2025-07-03 13:05:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3271
  Complete submission text file 0001950047-25-004828.txt   4730
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37355 | Film No.: 251104651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIKING THERAPEUTICS, INC. 12340 EL CAMINO REAL, STE 250 SAN DIEGO CA 92130
Business Address
Mancini Marianna (Reporting) CIK: 0001838112 (see all company filings)

Type: 144